MedPath

TO ASSESS THE LOWER JAW FRACTURE HEALING BY USING CALCITONIN HORMONE SPRAY

Phase 3
Completed
Conditions
Health Condition 1: S026- Fracture of mandibleHealth Condition 2: null- Patients with ASA 2 criteria
Registration Number
CTRI/2018/07/014749
Lead Sponsor
ARITRA ROY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
14
Inclusion Criteria

1. Patients with age group between 20 years to 40 years.

2. Patients with mandibular fractures.

3. Patients with ASA II criteria

Exclusion Criteria

1.Bone pathologies(tumours,cysts etc)

2.Patients with fracture(s) pertaining to regions other than mandible.

3.Patients with recent extraction of tooth/teeth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To assess that calcitonin promotes a faster bone healing in systemically compromised patients. <br/ ><br>2.To assess a better quality of life in these patients by fore said parameters. <br/ ><br>Timepoint: 1.To collect pre-op blood sample,extract plasma,and assess osteocalcin level. <br/ ><br>2.To assess pain by visual analogue scale from post-op day 1 to day 7 followed by assessment after every 7 days,upto 1 month. <br/ ><br>3.To collect post-op blood sample after 30th day,extract plasma,and assess osteocalcin level. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. To assess any side-effects of Calcitonin nasal sprayTimepoint: 1. Review patients weekly for four weeks
© Copyright 2025. All Rights Reserved by MedPath